Literature DB >> 29198926

Does the application of Ankaferd Blood Stopper rectally have positive effects on the healing of colorectal anastomosis and prevention of anastomotic leakage? An experimental study.

Serdar Kuru1, Kemal Kismet2, Yusuf Murat Bag2, Aziz Mutlu Barlas2, Mehmet Senes3, Murat Durak3, Nihat Yumusak4, Mustafa Kemal Urhan2, Turgut Cavusoglu2, Recep Pekcici2.   

Abstract

The purpose of this experimental study was to evaluate the potential effects on the healing of colorectal anastomoses of the rectal administration of Ankaferd Blood Stopper (ABS). Thirty Wistar-Albino male rats were randomly separated into 3 groups. In the sham group, only laparotomy and colonic mobilization was performed. In the other 2 groups, colon transection and anastomosis were carried out. Saline (2 mL, 0.9% NaCl) was given rectally via a feeding tube for 10 days after the surgical procedure in the sham and control groups. In Group 3 (ABS group), the rats were treated with rectally administered ABS (2 mL/day) for 10 days. In all groups, after the measurement of bursting pressures, tissue samples were collected for the measurement of tissue hydroxyproline and prolidase levels, and for histopathological evaluation on postoperative day 11. The rectal administration of ABS showed positive effects on bursting pressures, tissue prolidase and hydroxyproline levels, and the histopathological findings of colonic anastomosis. The rectal application of ABS had positive effects on the healing of colorectal anastomosis. As a natural product, it may be used effectively and safely to achieve better healing results after colorectal anastomosis.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anastomotic healing; Anastomotic leakage; Ankaferd Blood Stopper; Colorectal anastomosis; Experimental; Rats

Mesh:

Substances:

Year:  2017        PMID: 29198926     DOI: 10.1016/j.biopha.2017.11.140

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

1.  Effective Ankaferd Hemostat Treatment For Severe Intractable Chronic Deep Leg Ulcer Associated With Behçet's Disease.

Authors:  Rafiye Çiftçiler; Erdinç Çiftçiler; İbrahim Haznedaroğlu
Journal:  Arch Rheumatol       Date:  2019-04-26       Impact factor: 1.472

Review 2.  Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).

Authors:  Rafiye Ciftciler; Ali Erdinc Ciftciler; Umit Yavuz Malkan; Ibrahim C Haznedaroglu
Journal:  SAGE Open Med       Date:  2020-02-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.